Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
1.
J Fish Biol ; 86(2): 822-826, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25545049

ABSTRACT

Efficiency of the identification of eggs of Engraulis anchoita can be greatly improved by a method developed from egg measurements, using photography and the ImageJ programme, analysed by discriminant analysis using R software.

2.
Spinal Cord ; 49(3): 457-62, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21042332

ABSTRACT

STUDY DESIGN: Cross-sectional study. OBJECTIVES: To compare handrim biomechanics recorded during overground propulsion with those recorded during propulsion on a motor-driven treadmill. SETTING: Biomechanics laboratory. METHODS: In all, 28 manual wheelchair users propelled their own wheelchairs, at a self-selected speed, on a low-pile carpet and on a wheelchair accessible treadmill. Handrim biomechanics were recorded with an OptiPush instrumented wheelchair wheel. RESULTS: Across the two conditions, all handrim biomechanics were found to be similar and highly correlated (r>0.85). Contact angle, peak force, average force and peak axle moment differed by 1.6% or less across the two conditions. Although not significant, power output and cadence tended to be slightly higher for the treadmill condition (3.5 and 3.6%, respectively), owing to limitations in adjusting the treadmill grade. CONCLUSION: Based on the results of this study, a motor-driven treadmill can serve as a valid surrogate for overground studies of wheelchair propulsion.


Subject(s)
Biomechanical Phenomena/physiology , Exercise Test/standards , Exercise Tolerance/physiology , Paraplegia/rehabilitation , Physical Exertion/physiology , Wheelchairs/standards , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Paraplegia/physiopathology , Wheelchairs/adverse effects , Young Adult
3.
J Cell Biol ; 153(3): 491-501, 2001 Apr 30.
Article in English | MEDLINE | ID: mdl-11331301

ABSTRACT

The P2Y(2) nucleotide receptor (P2Y(2)R) contains the integrin-binding domain arginine-glycine-aspartic acid (RGD) in its first extracellular loop, raising the possibility that this G protein-coupled receptor interacts directly with an integrin. Binding of a peptide corresponding to the first extracellular loop of the P2Y(2)R to K562 erythroleukemia cells was inhibited by antibodies against alpha(V)beta(3)/beta(5) integrins and the integrin-associated thrombospondin receptor, CD47. Immunofluorescence of cells transfected with epitope-tagged P2Y(2)Rs indicated that alpha(V) integrins colocalized 10-fold better with the wild-type P2Y(2)R than with a mutant P2Y(2)R in which the RGD sequence was replaced with RGE. Compared with the wild-type P2Y(2)R, the RGE mutant required 1,000-fold higher agonist concentrations to phosphorylate focal adhesion kinase, activate extracellular signal-regulated kinases, and initiate the PLC-dependent mobilization of intracellular Ca(2+). Furthermore, an anti-alpha(V) integrin antibody partially inhibited these signaling events mediated by the wild-type P2Y(2)R. Pertussis toxin, an inhibitor of G(i/o) proteins, partially inhibited Ca(2+) mobilization mediated by the wild-type P2Y(2)R, but not by the RGE mutant, suggesting that the RGD sequence is required for P2Y(2)R-mediated activation of G(o), but not G(q). Since CD47 has been shown to associate directly with G(i/o) family proteins, these results suggest that interactions between P2Y(2)Rs, integrins, and CD47 may be important for coupling the P2Y(2)R to G(o).


Subject(s)
Heterotrimeric GTP-Binding Proteins/metabolism , Oligopeptides/metabolism , Receptors, Purinergic P2/metabolism , Receptors, Vitronectin/metabolism , Amino Acid Sequence , Antigens, CD/metabolism , CD47 Antigen , Calcium/metabolism , Carrier Proteins/metabolism , Focal Adhesion Kinase 1 , Focal Adhesion Protein-Tyrosine Kinases , GTP-Binding Protein alpha Subunits, Gi-Go , Humans , Integrins/metabolism , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , Phosphorylation , Point Mutation , Protein Binding , Protein-Tyrosine Kinases , Receptors, Purinergic P2/isolation & purification , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y2 , Receptors, Vitronectin/genetics , Receptors, Vitronectin/isolation & purification , Sequence Homology, Amino Acid , Signal Transduction
5.
J Gerontol Nurs ; 27(3): 8-18, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11915260

ABSTRACT

Nurses provide health services to an increasing number of older adults in acute care settings. Acute care nurses are committed to giving patients the highest quality care while recognizing the importance of delivering care in a cost-effective manner. In this study, a unit-based, nurse-centered geriatric program is evaluated. The program is designed to enhance the knowledge and skill of staff nurses in providing care to elderly patients. Both quantitative and qualitative methods are used to assess geriatric resource nurses' (GRNs) influence on quality and cost outcomes of the elderly participants. Patients age 65 years and older were randomly selected from two general medical units of a major academic tertiary care center in the southeastern United States. Data were collected during an 18-month period in 1996 and 1997. A total of 129 participants provided data for quantitative analysis. A subset of 34 participants (17 from the unit where GRNs were on staff and 17 from a control unit) was interviewed about their experience during hospitalization. This information was analyzed for common themes and trends using appropriate qualitative techniques. Demographic variables and common measures of illness severity and complexity showed comparable patient populations on the two units. However, results of quantitative analyses indicated significant differences between groups on admission for several of the health status measures. Participants on the unit without GRNs were found to have more problems with pain, incontinence, and mobility. Administrative measures showed the number of patients readmitted to the hospital within 31 days of discharge and the length of stay associated with this initial readmission were significantly lower on the unit with GRNs. The use of vest-type physical restraints was also less frequent on this unit. Elderly patients in both groups indicated they have special needs related to normal aging changes and chronic illnesses, resulting in higher levels of fragility and decreased energy reserves. They identified specific functional areas for which help was needed. These include assistance with bathing, eating, sleeping, mobility, and elimination. Fewer participants on the intervention unit reported decline in activities of daily living (ADL) function during hospitalization than did control participants. Participants in both groups stressed the importance of nurses' demonstrating understanding and caring when working with older individuals.


Subject(s)
Geriatric Nursing/standards , Nursing Staff, Hospital , Quality Assurance, Health Care , Aged/psychology , Aged, 80 and over , Attitude of Health Personnel , Female , Humans , Male , Middle Aged , Nursing Staff, Hospital/psychology , Outcome Assessment, Health Care , Patient Readmission , Patient Satisfaction , Quality Indicators, Health Care
6.
Am J Physiol Gastrointest Liver Physiol ; 279(1): G132-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10898755

ABSTRACT

The loss of cystic fibrosis transmembrane conductance regulator (CFTR)-mediated transepithelial HCO(3)(-) secretion contributes to the pathogenesis of pancreatic and biliary disease in cystic fibrosis (CF) patients. Recent studies have investigated P2Y(2) nucleotide receptor agonists, e.g., UTP, as a means to bypass the CFTR defect by stimulating Ca(2+)-activated Cl(-) secretion. However, the value of this treatment in facilitating transepithelial HCO(3)(-) secretion is unknown. Gallbladder mucosae from CFTR knockout mice were used to isolate the Ca(2+)-dependent anion conductance during activation of luminal P2Y(2) receptors. In Ussing chamber studies, UTP stimulated a transient peak in short-circuit current (I(sc)) that declined to a stable plateau phase lasting 30-60 min. The plateau I(sc) after UTP was Cl(-) independent, HCO(3)(-) dependent, insensitive to bumetanide, and blocked by luminal DIDS. In pH stat studies, luminal UTP increased both I(sc) and serosal-to-mucosal HCO(3)(-) flux (J(s-->m)) during a 30-min period. Substitution of Cl(-) with gluconate in the luminal bath to inhibit Cl(-)/HCO(3)(-) exchange did not prevent the increase in J(s-->m) and I(sc) during UTP. In contrast, luminal DIDS completely inhibited UTP-stimulated increases in J(s-->m) and I(sc). We conclude that P2Y(2) receptor activation results in a sustained (30-60 min) increase in electrogenic HCO(3)(-) secretion that is mediated via an intracellular Ca(2+)-dependent anion conductance in CF gallbladder.


Subject(s)
Bicarbonates/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Gallbladder/metabolism , Uridine Triphosphate/pharmacology , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Age Factors , Animals , Biological Transport/drug effects , Biological Transport/physiology , Calcium/metabolism , Chlorides/metabolism , Colforsin/pharmacology , Cystic Fibrosis/metabolism , Electric Conductivity , Electrophysiology , Epithelial Cells/metabolism , Hydrogen-Ion Concentration , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Purinergic P2 Receptor Agonists , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2Y2 , Stimulation, Chemical
7.
Am J Physiol Cell Physiol ; 279(2): C286-94, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10912994

ABSTRACT

Ligation of the main excretory duct of the rat submandibular gland (SMG) produces a pronounced atrophy that is reversed upon ligature removal. Based on previous studies by our group and others suggesting that P2Y(2) nucleotide receptors are upregulated in response to tissue damage, we hypothesized that P2Y(2) receptor activity and mRNA levels would increase after duct ligation and return to control levels after ligature removal. Our results support this hypothesis. Intracellular Ca(2+) mobilization in response to the P2Y(2) receptor agonist UTP in SMG cells was increased significantly after ligation periods of 1.5 to 7 days, whereas no significant response was observed in the contralateral, nonligated gland. P2Y(2) receptor mRNA, as measured by semiquantitative RT-PCR, increased about 15-fold after 3 days of ligation. These increases reverted to control levels by 14 days after ligature removal. In situ hybridization revealed that the changes in P2Y(2) receptor mRNA abundance occurred mostly in acinar cells, which also were more adversely affected by ligation, including an increase in the appearance of apoptotic bodies. These findings support the idea that P2Y(2) receptor upregulation may be an important component of the response to injury in SMG and that recovery of normal physiological function may signal a decreased requirement for P2Y(2) receptors.


Subject(s)
Calcium/metabolism , Receptors, Purinergic P2/metabolism , Submandibular Gland/metabolism , Animals , Female , Ligation , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2Y2 , Submandibular Gland/ultrastructure
8.
J Membr Biol ; 175(3): 235-44, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10833533

ABSTRACT

We examined the influence of serum and furosemide on K movement and cell volume in HCD57 cells, a murine erythroleukemia cell line, which require erythropoietin (EPO) for survival. We found that maintenance of cell volume depends on the concentration of serum in the culture medium. In isotonic medium containing 20% serum, HCD57 cells maintain their steady-state volume. In contrast, the cells shrink progressively as medium serum content is reduced. In serum-free medium, raising external K to 75 mm prevents cell shrinkage and a further increase in K to 145 mm results in swelling, revealing a role for K permeability in the regulation of cell volume. Of particular interest has been a serendipitous finding with furosemide. Below an external K concentration of 2.1 +/- 0.3 mm in medium containing 2% serum, furosemide inhibits K uptake, probably stemming from its well known inhibitory action on KCl cotransport. However, above that K concentration, furosemide stimulates K uptake in a dose-dependent manner. Moreover, furosemide potentiates cell shrinkage induced by serum withdrawal. These findings suggest that the transport machinery mediating cellular shrinkage, once primed by serum depletion, becomes receptive to a second stimulus.


Subject(s)
Furosemide/pharmacology , Potassium/metabolism , Symporters , Animals , Biological Transport/drug effects , Carrier Proteins/genetics , Chlorides/metabolism , Culture Media/pharmacology , Dose-Response Relationship, Drug , Leukemia, Erythroblastic, Acute , Mice , Rats , Serum Albumin, Bovine/pharmacology , Tumor Cells, Cultured , K Cl- Cotransporters
9.
Mol Cell Biochem ; 205(1-2): 115-23, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10821429

ABSTRACT

UTP activates P2Y, receptors in both 1321N1 cell transfectants expressing the P2Y2 receptor and human HT-29 epithelial cells expressing endogenous P2Y, receptors with an EC50 of 0.2-1.0 microM. Pretreatment of these cells with UTP diminished the effectiveness of a second dose of UTP (the IC50 for UTP-induced receptor desensitization was 0.3-1.0 microM for both systems). Desensitization and down-regulation of the P2Y2 nucleotide receptor may limit the effectiveness of UTP as a therapeutic agent. The present studies investigated the phenomenon of P2Y2 receptor desensitization in human 1321N1 astrocytoma cells expressing recombinant wild type and C-terminal truncation mutants of the P2Y2 receptor. In these cells, potent P2Y2 receptor desensitization was observed after a 5 min exposure to UTP. Full receptor responsiveness returned 5-10 min after removal of UTP. Thapsigargin, an inhibitor of Ca2+-ATPase in the endoplasmic reticulum, induced an increase in the intracellular free calcium concentration, [Ca2+]i, after addition of desensitizing concentrations of UTP, indicating that P2Y2 receptor desensitization is not due to depletion of calcium from intracellular stores. Single cell measurements of increases in [Ca2+]i induced by UTP in 1321N1 cell transfectants expressing the P2Y2 receptor indicate that time- and UTP concentration-dependent desensitization occurred uniformly across a cell population. Other results suggest that P2Y2 receptor phosphorylation/dephosphorylation regulate receptor desensitization/resensitization. A 5 min preincubation of 1321N1 cell transfectants with the protein kinase C activator, phorbol 12-myristate 13-acetate (PMA), reduced the subsequent response to UTP by about 50%, whereas co-incubation of PMA with UTP caused a greater inhibition in the response. The protein phosphatases-1 and -2A inhibitor, okadaic acid, partially blocked resensitization of the receptor. Furthermore, C-terminal truncation mutants of the P2Y2 receptor that eliminated several potential phosphorylation sites including two for PKC were resistant to UTP-, but not phorbol ester-induced desensitization. Down regulation of protein kinase C isoforms prevented phorbol ester-induced desensitization but had no effect on agonist-induced desensitization of wild type or truncation mutant receptors. These results suggest that phosphorylation of the C-terminus of the P2Y2 receptor by protein kinases other than protein kinase C mediates agonist-induced receptor desensitization. A better understanding of the molecular mechanisms of P2Y2 nucleotide receptor desensitization may help optimize a promising cystic fibrosis pharmacotherapy based on the activation of anion secretion in airway epithelial cells by P2Y, receptor agonists.


Subject(s)
Purinergic P2 Receptor Agonists , Receptors, Purinergic P2/metabolism , Astrocytoma/metabolism , Calcium/metabolism , Cell Adhesion , Cell Line , Colon/metabolism , Dose-Response Relationship, Drug , Epithelium/metabolism , Humans , Inositol Phosphates/metabolism , Ionophores/pharmacology , Mutagenesis , Okadaic Acid/pharmacology , Phorbol Esters/pharmacology , Phosphoric Monoester Hydrolases/metabolism , Protein Kinase C/metabolism , Receptors, Purinergic P2/chemistry , Receptors, Purinergic P2Y2 , Recombinant Proteins/metabolism , Time Factors , Tumor Cells, Cultured , Uridine Triphosphate/pharmacology
10.
Br J Pharmacol ; 130(1): 104-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10781004

ABSTRACT

1. Serotonin (5-hydroxytryptamine, 5-HT) has been shown to increase cyclic AMP production in dispersed cell aggregates from the major salivary glands of the rat. The goal of the present study was to identify the 5-HT receptor subtypes that mediate these effects in rat submandibular glands (SMG). 2. Among the 5-HT receptor subtypes identified in the rat, 5-HT(4(a,b)), 5-HT(6) and 5-HT(7(a,b,c)) activate adenylyl cyclase (AC). We used subtype specific primers to screen rat SMG by reverse transcription-PCR. Results indicate the presence of mRNA for 5-HT(4(b)) and 5-HT(7(a)) but not for 5-HT(4(a)), 5-HT(6) and 5-HT(7(b,c)). 3. In dispersed SMG cells, 5-carboxyamidotryptamine (5-CT), a 5-HT(7) receptor agonist, stimulated cyclic AMP synthesis with higher potency (EC(50)=27+/-5 nM) but lower efficacy than 5-HT, suggesting a 5-HT(7) component and an additional component in the response to 5-HT. The 5-HT(7) contribution was further supported by antagonism of the 5-CT effect by metergoline, a 5-HT(7) antagonist, which exhibited an affinity (K(i)=50 nM) similar to that obtained at the cloned 5-HT(7) receptor. 4. In the presence of a maximally effective concentration of 5-CT, 5-HT produced an additional increase in cyclic AMP production that was inhibited by the 5-HT(4) receptor antagonist, GR113808, suggesting that the second component of cyclic AMP production is mediated by 5-HT(4) receptors. 5. These findings indicate the presence in rat SMG of both 5-HT(4(b)) and 5-HT(7(a)) receptors positively coupled to AC.


Subject(s)
Adenylyl Cyclases/metabolism , Cyclic AMP/metabolism , Receptors, Serotonin/metabolism , Submandibular Gland/metabolism , Adenylyl Cyclases/drug effects , Animals , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Receptors, Serotonin/drug effects , Receptors, Serotonin, 5-HT4 , Serotonin/analogs & derivatives , Serotonin/pharmacology , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Submandibular Gland/drug effects
11.
J Mol Cell Cardiol ; 32(3): 391-403, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10731439

ABSTRACT

NF kappaB has been implicated as a downstream effector of G alphaq-coupled receptor signaling, but whether these and cytokine receptors activate NF kappaB similarly remains unclear. Stimulation of rat vascular smooth muscle cell G alphaq-coupled P2Y nucleotide receptors with UTP induces luciferase transcription from a sensitive and specific NF kappaB dependent promoter. However, these responses are only;15% of that to the reference cytokine IL-1 beta. IL-1 beta is a powerful stimulator of I kappaB alpha degradation, RelA nuclear import, and isoform specific NF kappaB enhancer binding in vitro, responses that are not detectable after P2Y receptor stimulation. Expression of two trans -dominant NF kappaB polypeptides suppresses induction of the NF kappaB reporter and also IL-1 beta stimulated monocyte chemoattractant-1 mRNA, which is not induced by UTP. In contrast, UTP induces higher expression of the endogenous COX-2 and IL-6 mRNAs than does IL-1 beta, implying that G alphaq-coupled receptor evokes additional NF kappaB-independent transcription factors in regulating these two genes. P2Y receptors are as effective as the reference growth factor PDGF-BB at inducing CREB, AP-1, SRE and NFAT transcription, which are largely unaffected by IL-1 beta treatment. NF kappaB is less efficiently activated then several other transcriptional effectors of G alphaq-coupled receptor signaling in vascular smooth muscle cells, and is instead preferentially activated by inflammatory cytokines.


Subject(s)
GTP-Binding Proteins/metabolism , I-kappa B Proteins , NF-kappa B/metabolism , Receptors, Interleukin-1/metabolism , Receptors, Purinergic P2/metabolism , Animals , Becaplermin , Cells, Cultured , Chemokine CCL2/genetics , Cyclooxygenase 2 , DNA-Binding Proteins/metabolism , GTP-Binding Protein alpha Subunits, Gq-G11 , Humans , Interleukin-1/metabolism , Interleukin-1/pharmacology , Interleukin-6/genetics , Isoenzymes/genetics , Membrane Proteins , Mice , Muscle, Smooth, Vascular/cytology , NF-kappa B p50 Subunit , Platelet-Derived Growth Factor/metabolism , Prostaglandin-Endoperoxide Synthases/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-sis , Rats , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2Y2 , Transcription Factor RelA , Transcription Factor RelB , Transcription Factors/metabolism , Uridine Triphosphate/metabolism , Uridine Triphosphate/pharmacology
12.
Am J Physiol ; 276(4): C777-87, 1999 04.
Article in English | MEDLINE | ID: mdl-10199807

ABSTRACT

Desensitization of P2Y2 receptor-activated anion secretion may limit the usefulness of extracellular nucleotides in secretagogue therapy of epithelial diseases, e.g., cystic fibrosis (CF). To investigate the desensitization process for endogenous P2Y2 receptors, freshly excised or cultured murine gallbladder epithelia (MGEP) were mounted in Ussing chambers to measure short-circuit current (Isc), an index of electrogenic anion secretion. Luminal treatment with nucleotide receptor agonists increased the Isc with a potency profile of ATP = UTP > 2-methylthioATP >> alpha,beta-methylene-ATP. RT-PCR revealed the expression of P2Y2 receptor mRNA in the MGEP cells. The desensitization of anion secretion required a 10-min preincubation with the P2Y2 receptor agonist UTP and increased in a concentration-dependent manner (IC50 approximately 10(-6) M). Approximately 40% of the anion secretory response was unaffected by maximal desensitizing concentrations of UTP. Recovery from UTP-induced desensitization was rapid (<10 min) at preincubation concentrations less than the EC50 (1.9 x 10(-6) M) but required progressively longer time periods at greater concentrations. UTP-induced total inositol phosphate production and intracellular Ca2+ mobilization desensitized with a concentration dependence similar to that of anion secretion. In contrast, maximal anion secretion induced by Ca2+ ionophore ionomycin was unaffected by preincubation with a desensitizing concentration of UTP. It was concluded that 1) desensitization of transepithelial anion secretion stimulated by the P2Y2 receptor agonist UTP is time and concentration dependent; 2) recovery from desensitization is prolonged (>90 min) at UTP concentrations >10(-5) M; and 3) UTP-induced desensitization occurs before the operation of the anion secretory mechanism.


Subject(s)
Epithelial Cells/physiology , Gallbladder/physiology , Receptors, Purinergic P2/physiology , Uridine Triphosphate/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Astrocytoma , Calcium/metabolism , Cells, Cultured , Dimerization , Epithelial Cells/drug effects , Humans , Inositol Phosphates/metabolism , Kinetics , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Polymerase Chain Reaction , Purinergic P2 Receptor Agonists , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y2 , Transfection , Tumor Cells, Cultured
13.
Crit Rev Oral Biol Med ; 10(2): 210-24, 1999.
Article in English | MEDLINE | ID: mdl-10759423

ABSTRACT

The effects of ATP on salivary glands have been recognized since 1982. Functional and pharmacological studies of the P2 nucleotide receptors that mediate the effects of ATP and other extracellular nucleotides have been supported by the cloning of receptor cDNAs, by the expression of the receptor proteins, and by the identification in salivary gland cells of multiple P2 receptor subtypes. Currently, there is evidence obtained from pharmacological and molecular biology approaches for the expression in salivary gland of two P2X ligand-gated ion channels, P2Z/P2X7 and P2X4, and two P2Y G protein-coupled receptors, P2Y1 and P2Y2. Activation of each of these receptor subtypes increases intracellular Ca2+, a second messenger with a key role in the regulation of salivary gland secretion. Through Ca2+ regulation and other mechanisms, P2 receptors appear to regulate salivary cell volume, ion and protein secretion, and increased permeability to small molecules that may be involved in cytotoxicity. Some localization of the various salivary P2 receptor subtypes to specific cells and membrane subdomains has been reported, along with evidence for the co-expression of multiple P2 receptor subtypes within specific salivary acinar or duct cells. However, additional studies in vivo and with intact organ preparations are required to define clearly the roles the various P2 receptor subtypes play in salivary gland physiology and pathology. Opportunities for eventual utilization of these receptors as pharmacotherapeutic targets in diseases involving salivary gland dysfunction appear promising.


Subject(s)
Receptors, Purinergic P2/physiology , Salivary Glands/physiology , Adenosine Triphosphate/physiology , Calcium/metabolism , GTP-Binding Proteins/physiology , Humans , Ion Channel Gating , Ion Channels/physiology , Molecular Biology , Permeability , Receptors, Purinergic P2/classification , Receptors, Purinergic P2/drug effects , Salivary Ducts/cytology , Salivary Gland Diseases/drug therapy , Salivary Glands/cytology , Salivary Glands/metabolism , Salivary Proteins and Peptides/metabolism , Second Messenger Systems/physiology
14.
Eur J Morphol ; 36 Suppl: 50-4, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9825893

ABSTRACT

The purpose of this investigation was to develop well-differentiated rat parotid and submandibular acinar cell lines. Acinar cells dissociated from rat parotid and submandibular glands were grown on Mitomycin C-treated 3T3 fibroblasts or Matrigel in primary culture and transfected by CaPO4 precipitation using a plasmid containing a replication-defective simian virus (SV40) genome. Cytokeratin analysis via indirect immunofluorescence and receptor mediated changes in intracellular calcium and cyclic AMP were assessed and used for the identification and selection of immortalized epithelial cells. Of the more than 60 clonal cell lines, four retained moderate to high levels of acinar differentiation through >60 passages. Ultrastructurally, there were tripartate junctional complexes and moderate amounts of rough endoplasmic reticulum and secretory granules. Functional studies indicated that beta-adrenoceptors, vasoactive intestinal peptide, and prostaglandin E1 were effective activators of intracellular cyclic AMP production in all cell lines. Alpha-adrenoceptors, muscarinic cholinoceptors, and P2U-purinoceptor agonists were effective in increasing intracellular inositol phosphate production and free calcium levels whereas substance P was ineffective. These data document the utility of the SV40 plasmid in immortalizing rat parotid and submandibular acinar cells that retain most of the features of acinar differentiation.


Subject(s)
Cell Culture Techniques/methods , Parotid Gland/cytology , Submandibular Gland/cytology , Animals , Calcium/metabolism , Cell Differentiation/physiology , Cell Line, Transformed/cytology , Cell Line, Transformed/drug effects , Cell Line, Transformed/metabolism , Cyclic AMP/physiology , Inositol 1,4,5-Trisphosphate/metabolism , Male , Muscarinic Agonists/pharmacology , Rats , Rats, Sprague-Dawley , Signal Transduction/physiology , Transfection , Tritium
15.
Eur J Morphol ; 36 Suppl: 170-5, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9825916

ABSTRACT

A growing body of information now supports the suggestion that P2 receptors for extracellular nucleotides (primarily ATP) have a role in regulating salivary gland function. There is solid pharmacological and molecular evidence for the presence of P2X ligand-gated ion channel nucleotide receptors (P2X4 and P2X7/P2Z). More recently, our group and others have obtained evidence that multiple P2Y G protein-coupled nucleotide receptors (P2Y1 and P2Y2) are also expressed. Our studies have focused on defining the conditions under which P2Y receptors are expressed, the functional consequences of their activation, and the importance of co-expression of P2X and P2Y receptors. Functional and molecular approaches have been used to identify the P2 subtypes in salivary glands and in salivary cell lines. Assays include measurement of changes in [Ca2+]i, changes in transcellular short circuit current in monolayers, and RT-PCR to assess changes in receptor mRNA levels. The main observations are: (1) P2Y1 receptor activity is present in the submandibular gland (SMG) of immature rats but decreases over the first four weeks following birth, although mRNA levels remain relatively constant; (2) P2Y2 receptors are present in the cell lines and are up-regulated during short-term culture of normal parotid, sublingual, and SMG cells and following ligation of the main excretory duct of SMG; and (3) the P2X subtypes, P2X4 and P2X7, and the P2Y subtypes, P2Y1 and P2Y2, are co-expressed in salivary glands and salivary cell lines, and exhibit distinct basolateral versus apical localization in polarized cell monolayers as well as discrete patterns of intracellular signaling.


Subject(s)
Receptors, Purinergic P2/genetics , Salivary Glands/chemistry , Salivary Glands/physiology , Animals , Epithelial Cells/chemistry , Epithelial Cells/physiology , Gene Expression/physiology , Neuropeptides/genetics , Parotid Gland/chemistry , Parotid Gland/cytology , Parotid Gland/physiology , RNA, Messenger/metabolism , Rats , Receptors, Purinergic P2X4 , Receptors, Purinergic P2X7 , Receptors, Purinergic P2Y1 , Salivary Glands/cytology , Sublingual Gland/chemistry , Sublingual Gland/cytology , Sublingual Gland/physiology , Submandibular Gland/chemistry , Submandibular Gland/cytology , Submandibular Gland/physiology
16.
J Biol Chem ; 273(45): 29437-44, 1998 Nov 06.
Article in English | MEDLINE | ID: mdl-9792648

ABSTRACT

Molecular determinants of P2Y2 receptor desensitization and sequestration have been investigated. Wild-type P2Y2 receptors and a series of five C-terminal truncation mutants of the receptor were epitope-tagged and stably expressed in 1321N1 cells. These constructs were used to assess the importance of the intracellular C terminus on 1) UTP-stimulated increases in intracellular calcium concentration, 2) homologous desensitization of the receptor, and 3) agonist-induced decreases in cell-surface density (receptor sequestration) of epitope-tagged receptors using fluorescence-activated cell sorting. The potency and efficacy of UTP were similar for the wild-type and all mutant P2Y2 receptors. Truncation of 18 or more amino acids from the C terminus increased by approximately 30-fold the concentration of UTP necessary to desensitize the receptor. Both the rate and magnitude of UTP-induced receptor sequestration were decreased with progressively larger truncations of the C terminus. Furthermore, the recovery from sequestration was slower for the most extensively truncated receptor. Complete desensitization was obtained with >50% of the original receptor complement remaining on the cell surface. Protein kinase C activation, which desensitizes the P2Y2 receptor, had no effect on sequestration, consistent with the ideas that desensitization and sequestration are discrete events and that agonist occupancy is required for receptor sequestration.


Subject(s)
Purinergic P2 Receptor Agonists , Uridine Triphosphate/pharmacology , Amino Acid Sequence , Cell Line , Dose-Response Relationship, Drug , Enzyme Activation , Humans , Molecular Sequence Data , Protein Conformation , Protein Kinase C/metabolism , Protein Structure, Secondary , Receptors, Purinergic P2/chemistry , Receptors, Purinergic P2Y2 , Recombinant Proteins/agonists , Recombinant Proteins/chemistry
17.
Am J Physiol ; 275(2): C367-74, 1998 08.
Article in English | MEDLINE | ID: mdl-9688590

ABSTRACT

Because of the lack of salivary gland cell lines suitable for Ussing chamber studies, a recently established rat parotid acinar cell line, Par-C10, was grown on permeable supports and evaluated for development of transcellular resistance, polarization, and changes in short-circuit current (Isc) in response to relevant receptor agonists. Par-C10 cultures reached confluence in 3-4 days and developed transcellular resistance values of >/=2,000 Omega . cm2. Morphological examination revealed that Par-C10 cells grew as polarized monolayers exhibiting tripartite junctional complexes and the acinar cell-specific characteristic of secretory canaliculi. Par-C10 Isc was increased in response to muscarinic cholinergic and alpha- and beta-adrenergic agonists on the basolateral aspect of the cultures and to ATP and UTP (through P2Y2 nucleotide receptors) applied apically. Ion replacement and inhibitor studies indicated that anion secretion was the primary factor in agonist-stimulated Isc. RT-PCR, which confirmed the presence of P2Y2 nucleotide receptor mRNA in Par-C10 cells, also revealed the presence of mRNA for the cystic fibrosis transmembrane conductance regulator and ClC-2 Cl- channel proteins. These findings establish Par-C10 cells as the first cell line of salivary gland origin useful in transcellular ion secretion studies in Ussing chambers.


Subject(s)
Anions/metabolism , Chloride Channels/biosynthesis , Epithelial Cells/physiology , Nerve Tissue Proteins/biosynthesis , Parotid Gland/cytology , Receptors, Purinergic P2/biosynthesis , Adenosine Triphosphate/pharmacology , Adrenergic alpha-Agonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , CLC-2 Chloride Channels , Carbachol/pharmacology , Cell Line , Cell Polarity , Chloride Channels/genetics , Chloride Channels/physiology , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Electric Conductivity , Electrophysiology/methods , Epithelial Cells/drug effects , Epithelial Cells/ultrastructure , Isoproterenol/pharmacology , Membrane Potentials/drug effects , Muscarinic Agonists/pharmacology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/physiology , Phenylephrine/pharmacology , Polymerase Chain Reaction , RNA, Messenger/biosynthesis , Rats , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/physiology , Receptors, Purinergic P2Y2 , Transcription, Genetic , Uridine Triphosphate/pharmacology
18.
In Vitro Cell Dev Biol Anim ; 34(1): 58-67, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9542637

ABSTRACT

Rat parotid salivary gland acinar cells were transfected by CaPO4 precipitation using a plasmid containing a replication-defective simian virus (SV40) genome. Out of 30 clonal cell lines, 2 were shown to have moderate to high levels of cytodifferentiation and salivary gland acinar cell function. Functional studies with the two cell lines indicated that the beta-adrenergic agonist (isoproterenol), vasoactive intestinal peptide prostaglandin E1, and forskolin were effective activators of intracellular cyclic adenosine 3':5'-cyclic monophosphate production. Phenylephrine, carbamylcholine, and UTP were effective in increasing inositol phosphate production and intracellular free calcium levels, whereas substance P was without affect. Utilizing indirect immunofluorescence analysis, both cell lines were shown to express the SV40 large T antigen. Electron microscopic evaluation documented moderate to high levels of cytodifferentiation with the maintenance of tripartite junctional complexes, cellular polarization, and presence of moderate amounts of secretory granules and rough endoplasmic reticulum. The two cell lines had doubling times of 22 and 36 h, respectively.


Subject(s)
Cell Line, Transformed , Parotid Gland/cytology , Simian virus 40 , 3T3 Cells , Animals , Male , Mice , Plasmids , Rats , Rats, Sprague-Dawley , Transfection
19.
Ann N Y Acad Sci ; 842: 70-5, 1998 Apr 15.
Article in English | MEDLINE | ID: mdl-9599295

ABSTRACT

Experiments were performed to document the presence of G protein-coupled P2Y nucleotide receptors in rat salivary glands and to examine changes in receptor expression during development and under conditions in which gland architecture is altered. The results indicate that, as opposed to mature rat submandibular gland (SMG), immature glands express functional P2Y1 receptors. P2Y1 receptor activity was highest at birth and declined over the next four weeks to undetectable levels. P2Y1 receptor mRNA levels remained constant over this time course, suggesting that receptor activity is regulated at some point other than transcription. Conversely, short-term culture of cells from the three major salivary glands resulted in upregulation of functional P2Y2 receptors. Responses to the P2Y2-selective agonist, UTP, were obtained after 3 h in culture and were maximal by 72 hours. This increase was paralleled by increased steady-state P2Y2 receptor mRNA levels. Upregulation of P2Y2 receptors also occurred in vivo following ligation of the main excretory duct of the SMG. These studies suggest that nucleotide receptors are dynamically regulated during development and as a result of perturbations to gland architecture.


Subject(s)
Gene Expression Regulation, Developmental , Receptors, Purinergic P2/biosynthesis , Sublingual Gland/metabolism , Submandibular Gland/metabolism , Animals , Calcium/metabolism , Carbachol/pharmacology , Cells, Cultured , Muscarinic Agonists/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/physiology , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y2 , Sublingual Gland/drug effects , Sublingual Gland/growth & development , Submandibular Gland/drug effects , Submandibular Gland/growth & development , Uridine Triphosphate/pharmacology
20.
Am J Physiol ; 273(3 Pt 1): C1100-7, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9316432

ABSTRACT

In contrast to the widespread expression of G protein-coupled P2Y2 receptors for extracellular nucleotides in permanent cell lines of salivary gland origin, there is less evidence for robust P2Y2 receptor activity in normal rat salivary gland cells assayed immediately after isolation. We examined the effect of short-term culture (3 h to 6 days) of normal rat submandibular gland (SMG) cells on P2Y2 receptor activity and mRNA expression. Results indicate that increases in the intracellular free Ca2+ concentration in SMG cells in response to the P2Y2 receptor agonist UTP (100 microM) were detectable after 3 h in culture and that after 3 days in culture the magnitude of the response to UTP was similar to that obtained with maximal muscarinic cholinoceptor activation. The Ca2+ mobilization response exhibited the pharmacological profile (UTP = ATP > 2-methylthioadenosine 5'-triphosphate) typical of the P2Y2 receptor subtype and was accompanied by enhanced production of inositol phosphates, reflecting the activation of phospholipase C ubiquitously associated with P2Y2 receptors. The time-dependent increase in P2Y2 receptor activity was accompanied by an increase in the steady-state level of P2Y2 receptor mRNA, as assessed by reverse transcription-polymerase chain reaction. Other studies revealed that the increased P2Y2 receptor activity was independent of cell proliferation, was similar in serum-containing and defined culture media, and was blocked by inhibitors of transcription and translation. Upregulation of the P2Y2 receptor was observed in both acinar cell- and ductal cell-enriched cultures of the SMG and in cells isolated from rat parotid and sublingual glands but not in cells isolated from the pancreas. These in vitro results were complemented by in vivo studies in which P2Y2 receptor activity and mRNA levels were increased in SMG after ligation of the main excretory duct but were not increased in the contralateral, nonligated gland. These findings suggest that changes in the expression and activity of the P2Y2 receptor in salivary gland cells may be related to pathological challenges to the gland in vivo.


Subject(s)
Receptors, Purinergic P2/biosynthesis , Salivary Glands/metabolism , Submandibular Gland/metabolism , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Animals , Calcium/metabolism , Cells, Cultured , In Vitro Techniques , Inositol Phosphates/metabolism , Kinetics , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2Y2 , Thionucleotides/pharmacology , Time Factors , Transcription, Genetic/drug effects , Up-Regulation , Uridine Triphosphate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...